Why most probiotics never
actually reach your gut

The basic problem nobody explains

Walk into any pharmacy in India and you will find a shelf of probiotic products. Capsules, sachets, chewables, drinks. They list bacterial strains, CFU counts, and health claims. What very few of them tell you is what happens to those bacteria between the moment you swallow and the moment they arrive at the place where they need to work.

What happens is this: the capsule enters your stomach, where the gastric acid environment sits at a pH of roughly 1.5 to 3.5. Most bacteria cannot survive at this pH. Lactobacillus strains, Bifidobacterium strains, and most of the probiotics on those pharmacy shelves were not designed to survive stomach acid because they are in standard capsules or tablets that begin dissolving the moment they contact gastric fluid.

By the time what remains reaches the small intestine, which is where probiotic bacteria actually colonise, attach to cells, and perform their functions, the majority of what you swallowed is dead or severely compromised. One study measuring the survival of common probiotic strains through simulated gastric conditions found that under two hours of exposure to pH 2.0, viable cell counts dropped by 99 percent or more for several commonly used strains.

This is not a fringe concern or a technicality. It is a fundamental issue with how most probiotic products on the market are formulated, and it is the reason why the clinical evidence for probiotics is so inconsistent. The trials that show strong outcomes almost universally use enteric coated or delayed release delivery formats. The trials that show weak outcomes typically use standard capsule formats. The strains are often identical. The delivery is not.

Understanding pH and bacterial survival

pH is a measure of acidity on a scale from 0 to 14. Lower numbers are more acidic. Neutral is 7. Your stomach, when actively digesting, sits at pH 1.5 to 3.5. Your small intestine, where probiotic bacteria need to land and colonise, sits at pH 6 to 7.4.

Bacteria have evolved to function within specific pH ranges. Most probiotic strains are adapted to the relatively neutral environment of the intestine. They are not adapted to gastric acid. Exposure to pH below 3.0 denatures their proteins, disrupts their cell membranes, and kills them within minutes.

There are a few strains with meaningful acid tolerance. Lactobacillus rhamnosus GG has among the best natural acid resistance of any clinically used probiotic strain, which is one reason it appears so consistently in the research literature. Saccharomyces boulardii is a yeast rather than a bacterium, which gives it a fundamentally different cell wall structure and significantly better acid tolerance than most bacterial probiotics. These properties do not make standard delivery adequate for them. They mean they survive marginally better than most. Delayed release delivery still produces substantially higher intestinal delivery for both.

What delayed release actually means

A delayed release capsule is designed with one goal: to remain physically intact through the acidic environment of the stomach and begin dissolving only when it reaches the higher pH environment of the small intestine.

There are two main approaches to achieving this in practice.

Enteric coated capsules

A standard capsule with an additional coating applied to its exterior. The coating is made from materials that are stable at low pH (stomach acid) but dissolve rapidly at higher pH (intestine). Cellulose acetate phthalate and Eudragit polymers are common coating materials. Enteric coating is effective but the coating process adds manufacturing complexity and cost, and the uniformity of the coating affects performance.

HPMC capsules

Hydroxypropyl methylcellulose capsules are made from a plant-derived polymer that has inherently different dissolution characteristics from standard gelatin. HPMC dissolves more slowly than gelatin and can be formulated to provide meaningful delayed release without an additional coating step. They are vegetarian, which matters for a significant portion of Indian consumers, and they perform well under the high heat and humidity conditions of ICH Zone IVb, which governs pharmaceutical and nutraceutical stability testing in India.

HPMC is the format used in pharmaceutical-grade probiotic products, which is why it is the format you find in the clinical trials that show strong outcomes. It is also why it matters what type of capsule your probiotic comes in, not just what strains are listed on the label.

What to look for on the label

When you are evaluating a probiotic product, the label contains everything you need to make a reasonable judgment about whether it is likely to work. Here is what to look for in order of importance.

Capsule type

The label should specify either "delayed release," "enteric coated," or "HPMC capsule." If it says "vegetarian capsule" without specifying the type, that is often HPMC but not guaranteed. If it says "gelatin capsule" or does not mention capsule type at all, assume standard dissolution and therefore significant acid exposure. This is the most important item on the label and the least prominently displayed on most products.

Strain specificity

Generic labels that say "Lactobacillus acidophilus" or "probiotic blend 10 billion CFU" tell you almost nothing useful. The clinical evidence for probiotics is strain-specific. Lactobacillus rhamnosus GG (the specific designation is ATCC 53103 or LGG) has clinical evidence. Lactobacillus rhamnosus from a different supplier under a different strain designation may have no clinical evidence at all despite being technically the same species. Strain designation matters.

CFU count at expiry, not at manufacture

Most probiotic products list CFU at the time of manufacture. Bacteria die during storage. A product with 10 billion CFU at manufacture may have 2 billion CFU by the time you buy it, and fewer still by the time you finish the bottle. Look for products that list CFU at expiry ("guaranteed through expiry") rather than at manufacture. This requires the manufacturer to account for die-off in their formulation, which typically means they start with a higher count and use better storage conditions.

Storage requirements

Some probiotic strains require refrigeration to maintain viability. If a product claims to be shelf-stable but contains strains known to be temperature-sensitive, that is a red flag. Lyophilised (freeze-dried) formats can extend shelf stability significantly without refrigeration, which matters in India where cold chain reliability varies considerably.

The pharmacy shelf problem in India

Indian pharmacies stock dozens of probiotic products. Bifilac, Vizylac, Econorm, Sporlac, and others are widely prescribed and purchased. Most of them are in standard capsule formats, and most of them are positioned as during-antibiotic support rather than post-antibiotic recovery support.

During-antibiotic use has a specific pharmacological issue beyond the delivery problem: most of those bacteria are killed by the antibiotic itself if taken at the same time. The timing guidance on most pharmacy probiotics (take two hours after your antibiotic dose) partially addresses this but does not eliminate it. Saccharomyces boulardii is the exception because it is a yeast and is not affected by antibacterial antibiotics, which is why it appears on its own in products like Econorm.

The point is not that these products are useless. Some of them contain genuinely good strains. The point is that delivery format and timing relative to your course are both as important as strain selection, and most pharmacy products are not optimised for either.

What this means practically

If you are taking probiotics during or after an antibiotic course and using a standard capsule product from a pharmacy shelf, you are getting some benefit but substantially less than the clinical evidence for those strains would suggest. The trials those strains are based on used delivery formats designed to survive the stomach.

The things worth looking for when choosing a probiotic for post-antibiotic use: a delayed release HPMC capsule format, strain designations that include the specific identifier (LGG ATCC 53103, not just Lactobacillus rhamnosus), a CFU count guaranteed at expiry rather than at manufacture, and the inclusion of Saccharomyces boulardii as the acid-tolerant yeast component alongside bacterial strains.

These criteria are not marketing language. They are what separates products that have strong clinical evidence behind them from products that are trading on the general reputation of probiotics without the formulation to back it up.